Reminder…..Registration for 340B!!!
July 7, 2021
There is still time to register for 340B! Registration is from July 1 – July 15 for effective start date of October 1. If you
Our Blog
The Ryan White CARE Act
July 7, 2021
Ryan White was born with hemophilia. To manage his hemophilia, Ryan received regular blood transfusions. When he was 13 years old, Ryan was diagnosed with
HHS Advisory Opinion on Contract Pharmacies FINALLY!!!
December 30, 2020
HHS released an advisory opinion regarding certain manufacturer’s refusal to sell 340B drugs through a contract pharmacy. See documents attached. “The Office of the General
Landmark Supreme Court Ruling: State Regulation of PBM Reimbursement Rates-How this helps protect the revenue for 340B entities
December 14, 2020
https://www.pharmacytimes.com/news/landmark-supreme-court-ruling-state-regulation-of-pbm-reimbursement-rates This will help protect the recent trend by the PBM’s to lower the reimbursement for a 340B drug dispensed vs a non-340B drug. Already
Health Resources and Services Administration (HRSA) released the procedures and requirements
December 14, 2020
Health Resources and Services Administration (HRSA) released the procedures and requirements for the 340B Program’s Administrative Dispute Resolution (“ADR”). This has been 10 years in
Hospitals Sue HHS over Pharma 340B Pricing
December 11, 2020
Hospitals Sue HHS over Pharma 340B Pricing for contract Pharmacy attack.See complaint attached.
US House letter to HHS regarding Kalderos and their new program
October 28, 2020
US House letter to HHS regarding Kalderos and their new program called “340B Pay”. 340B Pay will uproot the current 340B cash flow model and
Health Centers Sue HHS over Pharma 340B Pricing
October 21, 2020
Health Centers Sue HHS over Pharma 340B Pricing for Contract Pharmacy attack.See complaint attached.
RWC-340B and 340B Grantee Plaintiffs File Lawsuit Against HHS/HRSA
October 9, 2020
RWC-340B and 340B Grantee Plaintiffs File Lawsuit Against HHS/HRSA to Protect 340B Contract Pharmacy Program from Manufacturer Attacks. See complaint attached.
AstraZeneca and Sanofi Block Access to 340B
October 1, 2020
AstraZeneca and Sanofi Block Access to 340B Contract Pharmacy Pricing but not Novartis. See the letter from Sanofi attached.
